ArticleLeukemia & lymphoma2015

The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?

Joshua F Zeidner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.